Bayer AG Company Profile (OTCMKTS:BAYRY)

Analyst Ratings

Consensus Ratings for Bayer AG (OTCMKTS:BAYRY) (?)
Ratings Breakdown: 6 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.54)
Consensus Price Target: $130.00

Analysts' Ratings History for Bayer AG (OTCMKTS:BAYRY)
Show:
DateFirmActionRatingPrice TargetActions
5/26/2016Sanford C. BernsteinReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/25/2016Commerzbank AGUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/25/2016Deutsche Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/25/2016DZ Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/24/2016Citigroup Inc.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/24/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/24/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Credit Suisse Group AGDowngradeOutperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2016Nord/LBReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2016Barclays PLCUpgradeUnderweight -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/10/2015HSBCUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2015Jefferies GroupBoost Price TargetHold$130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/26/2015Societe GeneraleReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015Equinet Institutional ServicesUpgradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015Morgan StanleyDowngradeOverweight -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/10/2014Erste GroupUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/25/2014BNP ParibasInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2014Kepler Capital MarketsUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Bayer AG (OTCMKTS:BAYRY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/29/2015Q3$1.65$1.88ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015$2.35$2.33ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015$1.35ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2014$2.05ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/20/2014$2.47$2.35ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bayer AG (OTCMKTS:BAYRY)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Bayer AG (OTCMKTS:BAYRY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Bayer AG (OTCMKTS:BAYRY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Bayer AG (OTCMKTS:BAYRY)
DateHeadline
07/29/16 07:42 PMUPDATE 1-Bayer says will halt future U.S. sales of insecticide - CHICAGO, July 29 (Reuters) - The agricultural unit of German chemicals company Bayer AG will halt future U.S. sales of an insecticide that can be used on more than 200 crops after losing a fight with...
07/29/16 06:14 PMBayer says will halt future U.S. sales of insecticide -
07/28/16 05:24 PMJudge rules against nearly 1,300 lawsuits over Bayer's Mirena IUD - [Reuters] - A New York federal judge has ruled in favor of Bayer AG against nearly 1,300 lawsuits filed by women who say they suffered internal injuries from the company's Mirena intra-uterine contraceptive device. U.S. District Judge Cathy Seibel in White Plains said on Thursday that there was no way for the lawsuits to continue after her earlier ruling barring crucial testimony from plaintiffs' experts. Lawsuits against Bayer over Mirena started to pile up in 2011 and were consolidated in the New York court in 2013.
07/28/16 03:30 PMJudge rules against some 1,300 lawsuits over Bayer's Mirena IUD -
07/27/16 08:59 AMBayer's Strong Second-Quarter Figures Make Weak Case for Higher Monsanto Bid -
07/25/16 03:17 PMMonsanto (MON) Calls Bayer’s Bid “Financially Inadequate”, Bloomberg TV Reports
07/24/16 05:23 AM[$$] Week Ahead Corporate Diary: Chemical groups reporting results -
07/21/16 08:55 AMWill A White Knight Emerge With Buyout Bid For Monsanto? -
07/20/16 02:31 PMWeitz Funds Comments on Monsanto -
07/20/16 12:43 PM[$$] Stronger Chinese Patent Laws Also Help U.S. Companies -
07/20/16 10:49 AMWhy Bayer AG (ADR)(OTCMKTS:BAYRY) Closed In Red? - Journal Transcript
07/20/16 10:49 AMMonsanto Says Bayer's Revised Offer Financially Inadequate - Quick Facts
07/19/16 02:46 PMMonsanto Company (MON) Rebuffs “Financially Inadequate” Bayer Deal
07/19/16 08:55 AMHigh Consolidation in Agricultural Input: Creating Value for Investors
07/19/16 08:55 AMCiti Analysts Respond To Recent Monsanto Deal Talk
07/19/16 08:55 AMMonsanto Says Bayer''s Revised Offer Financially Inadequate - Quick Facts
07/18/16 07:43 AMTracking Ken Fisher's Fisher Asset Management Portfolio - Q2 2016 Update
07/17/16 07:27 AMHow Analysts Feel About Bayer AG (ADR) (OTCMKTS:BAYRY)? - Consumer Eagle
07/16/16 02:42 PMNew Broker Ratings For Bayer AG (BAYRY) - FTSE News
07/14/16 02:23 PMBayer Keeps Its Monsanto Dream Alive -
07/14/16 11:36 AMGermany's Bayer increases offer for seed company Monsanto -
07/14/16 11:29 AMBayer is not letting Monsanto off the hook -
07/14/16 11:18 AMBayer increases Monsanto offer and provides certainty on financing and regulatory matters - [at noodls] - Leverkusen, July 14, 2016- Over the past several weeks Bayer has engaged in private talks with Monsanto. Following receipt of additional information Bayer has raised its all-cash offer to Monsanto shareholders ...
07/14/16 11:14 AMMonsanto (MON) Stock Surging, Bayer Ups Offer -
07/13/16 08:11 PMMonsanto Might Acquire BASF’s Agricultural Solutions Unit
07/13/16 02:46 PMBayer Expands Drug Discovery Collaboration with X-Chem
07/12/16 06:13 AMNot intended for UK Media -- Bayer and X-Chem Expand Drug Discovery Collaboration to Discover Novel Medicines - [at noodls] - Berlin, July 12, 2016 - Bayer and X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, ...
07/10/16 07:30 AMBayer AG (BAYRY) Broker Price Targets For The Coming Week - Fiscal Standard
07/05/16 07:21 AMBayer supports novel ideas to increase crop productivity - [at noodls] - Monheim, July 5, 2016- With its open innovation program Grants4Traits, Bayer now supports novel ideas that will lead to innovative commercial seed products. Researchers at universities, other scientific ...
07/04/16 02:42 PMBroker Outlook For The Week Ahead Bayer AG (BAYRY) - Fiscal Standard
07/04/16 04:11 AMBayer Focuses on Scientific Education, Innovations to Enhance Cattle Health - [at noodls] - Dublin, Ireland, July 4, 2016- The global livestock production landscape is in transition. To support veterinarians in navigating current and future challenges, Bayer focused on scientific education and ...
07/02/16 10:25 AMIf Bayer Deal Falls Through, Could Monsanto See $92 Handle?
07/01/16 03:29 PMMonsanto Suffers 37% Decline in Q3 Profits (MON, BAYRY) -
07/01/16 08:40 AMCiti Ups Monsanto Target After Management Meetings, Still Not Bullish -
06/30/16 01:25 PMMonsanto’s Grant Seeks Partner at Dealmaking Dance He Started -
06/30/16 10:36 AMBayer Quietly Claims Its Liver Cancer Prize - Seeking Alpha
06/30/16 10:36 AMEU Reportedly To Open Review Of Bayer-Monsanto Deal
06/30/16 08:45 AMEU plans careful scrutiny of possible Bayer/Monsanto deal -
06/29/16 02:42 PMBayer AG (BAYRY) Current Analyst Ratings - Fiscal Standard
06/29/16 02:06 PMMonsanto's Weak Hand -
06/29/16 10:55 AMEU to Open Review of Bayer, Monsanto Deal
06/28/16 02:56 PMMonsanto Earnings: What to Watch
06/28/16 12:37 PMWhat to Look for When Monsanto (MON) Posts Q3 Earnings -
06/28/16 08:51 AMNot intended for U.S. and UK Media: Phase III data at ESMO 18th World Congress on Gastrointestinal Cancer (WCGC): -- Bayer’s Regorafenib Significantly Improves Overall Survival in Patients with Unresectable Liver Cancer -- Initial results f - [at noodls] - Berlin, June 28, 2016 - Bayer today announced results from the Phase III RESORCE trial investigating its oncology compound regorafenib in patients with unresectable hepatocellular carcinoma (HCC) who progressed ...
06/28/16 08:03 AM9:03 am Bayer AG announces that results from the Phase III RESORCE trial show that Stivarga tablets achieved a median overall survival improvement in patients with unresectable hepatocellular carcinoma who progressed after treatment with Ne -
06/27/16 02:23 PMDoes Brexit Affect The Bayer-Monsanto Deal? - Seeking Alpha
06/27/16 07:27 AMGrim Year for U.K. M&A Made More Uncertain by Britain’s Decision to Leave EU
06/27/16 07:27 AMNext Weeks Broker Price Targets For Bayer AG (BAYRY) - Fiscal Standard
06/25/16 02:44 PMHow Analysts Rated Bayer AG (ADR) (OTCMKTS:BAYRY) Last Week? - Press Telegraph
06/24/16 10:30 AMIt's Time To Sell One Of My Favorite Companies -

Social

About Bayer AG

Bayer AG logoBayer AG is a Germany-based chemical and pharmaceutical company. The Company's business operations are organized into three segments: Bayer HealthCare, Bayer CropScience and Bayer MaterialScience, supported by the service companies Bayer Business Services, Bayer Technology Services and Currenta. Bayer HealthCare researches, develops, manufactures and markets products to improve the health of people and animals. Bayer CropScience is engaged in the crop protection and non-agricultural pest control. Bayer MaterialScience supplies polymers, and develops solution for a range of applications. The Company's subsidiaries include Adverio Pharma GmbH, AgrEvo Verwaltungsgesellschaft mbH, Alcafleu Management GmbH & Co KG, Bayer Beteiligungsverwaltung Goslar GmbH, Bayer MaterialScience Customer Services GmbH, Schering-Kahlbaum Gesellschaft mit beschraenkter Haftung, proPlant Gesellschaft fuer Agrar- und Umweltinformatik mbH and KOSINUS Grundstuecks-Verwaltungsgesellschaft mbH & Co Gamma OHG.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: BAYRY
  • CUSIP:
Key Metrics:
  • Previous Close: $107.69
  • 50 Day Moving Average: $101.357
  • 200 Day Moving Average: $108.338
  • P/E Ratio: 18.902
  • P/E Growth: 1.500
  • Market Cap: $89.05B
  • Beta: 1.48
  • Current Year EPS Consensus Estimate: $8.02 EPS
  • Next Year EPS Consensus Estimate: $8.81 EPS
Additional Links:
Bayer AG (OTCMKTS:BAYRY) Chart for Saturday, July, 30, 2016